SafeMinds Authored Commentary, Critiques & Presentations

SafeMinds has actively critiqued much of the research on the vaccine-autism link since 2000. Generation Rescue has provided two websites, fourteenstudies.org and putchildrenfirst.org, that provide critiques of the flaws of studies that are often used to refute the vaccine-autism link. Those websites include critiques written by SafeMinds, such as Analysis and Critique of the CDC’s Handling of the Thimerosal Exposure Assessment Based on VSD Information written as critique of the Verstraetten study. You will find other commentaries and critiques by SafeMinds below.

Urinary Excretion Study – SafeMinds Commentary (2/22/12)

Brief: Environment vs. Genetics
Why The Autism Epidemic Demands a New Approach

Background, Supporting Research and Analysis of Current Research Funding

Vaccines and Autism: What do Epidemiological Studies Really Tell Us?

This paper examines the epidemiological studies surrounding “autism and the MMR vaccine” and “autism and thimerosal”. It explains in detail the conflicts of interest, poor designs and unsupported conclusions in 16 different studies related to autism and vaccines. It includes the opinions of other authorities on these studies as well.

On-Time Vaccine Receipt in the First Year Does Not Adversely Affect Neuropsychological Outcomes (June 2010)

SafeMinds tells you what’s wrong with this study and Sallie Bernard’s comments are published in Pediatrics

SafeMinds Safety First Comment to National Vaccine Program

A Roadmap to a Safety First Agenda for the National Vaccine Program: Suggestions for the Draft National Vaccine Plan from a Patient Safety Perspective (June 2009)

SafeMinds Response to National Vaccine Plan of 2008 Draft  (March 2009)

Latest Autism Gene Findings… Not Much (April 2009)

There’s a familiar rhythm to the most prominent autism gene hunt publications. Their authors hype their newly minted study aggressively in the media. The prestigious journals that publish them lend their imprimatur to press releases that say, “this study is a big deal.” The findings sound impressive in the press release (and the authors get plenty of time on camera and in leading newspapers to tell us how truly impressive they are). In the meantime–in papers that are so densely written that making sense of what they really say requires far more reflection than the media hype cycle permits–skillfully concealed evidence reveals the truly important new in the findings: the authors whisper quietly (if at all) that the new analysis negates the most important findings of some of the most prominent previous gene hunts, while crucial detail on their new findings is often relegated to “supplementary material” that’s not available on the publication date.  Read more.

SafeMinds Sponsors and Attends 25th International Neurotoxicology Conference

NIH & AUTISM: A Case Study in Barriers to Progress in Environmental Medicine
October 2008 Authored by Sallie Bernard, Mark Blaxill and Theresa Wrangham

Read paper or poster.

SafeMinds and National Autism Association – NIEHS-Sponsored Symposium on Environmental Factors in Neurodevelopmental Disorders (August 2005)

In August 2005, a two-day symposium was held in Bethesda, Maryland on the role of environmental factors in the pathogenesis of autism spectrum disorders and related neurodevelopmental conditions. Dr. Kenneth Olden – then the director of NIEHS – conceived the idea for the conference, and the meeting was sponsored by NIEHS. Two autism research groups, the Coalition for SafeMinds and the National Autism Association, co-organized the meeting with a team of researchers they recruited to the effort.

MMR and Autism in Perspective:  The Denmark Story (2004)

Authored by Carol Stott, Ph.D.; Mark Blaxill; Andrew J.Wakefield, M.B., FRCS for the Journal of American Physicians and Surgeons

Autism and related developmental disorders, once rare, are now becoming a common problem in Western countries. Although frequently catastrophic in their effects, the current crisis has come up against a “duck-and-cover” mentality from many a dusty corner of conventional medical wisdom.  Read more.

Something is Rotten in Denmark (May 2004)

An Analysis of the Failures and Conflicts of Interest in Several Studies Used by IOM Vaccine Safety Committee Report. View Power Point

Generation Zero Full Analysis with Charts (2004)

Thomas Verstraeten’s First Analyses of the Link Between Vaccine Mercury Exposure and the Risk of Diagnosis of Selected Neuro-Developmental Disorders Based on Data from the Vaccine Safety Datalink: November-December 1999.  Click here for full analysis with charts, click here for Generation Zero Synopsis.

Analysis and Critique of the CDC’s Handling of the Thimerosal Exposure Assessment Based on VSD Information (October 2003)

View Power Point

Analysis of the Danish Autism Registry Data Base in Response to the Hviid et al Paper on Thimerosal in JAMA (October 2003)

A large percentage of diagnosed autism cases are lost from the Danish registry each year. In the ten years preceding 2000, 815 cases were lost, more than the 710 remaining in the registry in 2000. The vast majority of those lost cases would represent older children in the 2000 registry. Since the relative risk of the Hviid study is based on finding fewer older thimerosal-exposed children than younger unexposed children, the validity of their conclusion exonerating thimerosal in autism is questionable. More likely, the finding is a result of missing records rather than true lower incidence rates among the exposed group. Read more.

Danish Thimerosal-Autism Study in Pediatrics: Misleading and Uninformative on Autism-Mercury Link (September 2003)

A report by Madsen et al. published by the American Academy of Pediatrics in their journal Pediatrics claims to provide evidence against a link between autism rates and the mercury in thimerosal, a preservative used in childhood vaccines. Unfortunately, the study analysis is full of flaws and inaccuracies, invalidating the conclusions regarding thimerosal. The study adds little of value to the scientific literature on autism and mercury.  Read more.

SafeMinds Press Release:  Vaccine Health Officials Manipulate Autism Records to Quell Rising Fears over Mercury in Vaccines: Safe Minds Cites Unscientific Trending Techniques and Conflicts of Interest, Call Study’s Conclusions Doubtful

Commentary on Croen et al. (2002) The Changing Prevalence of Autism in California (April 2003)

Authored by Blaxill, Baskin and Spitzer Journal of Autism and Developmental Disorders, Vol. 33, No. 2, April 2003

Lisa Croen and colleagues (Croen, Grether, Hoogstrate, & Selvin, 2002) suggest that the real incidence of autism has not increased. They propose instead that a pattern of “diagnostic substitution” has moved Californian patients who would previously have been diagnosed as mentally retarded (Croen, Grether, & Selvin, 2001) into the autism category. Their calculations purport to demonstrate that over 100% of the increase in autism from 1987–1994 is an artifact of changes in diagnostic practices. In your editorial commentary, Eric Fombonne praises the study, and claims “Croen et al. carefully analyzed the California dataset.”  Read more.

February 15, 2021

Decreased Phenol Sulfotransferase Linked to Common Autism Biomarker

Hyperserotonemia Has Been Associated with ASD for Decades for Unknown Reasons Until Now Hyperserotonemia is the state of increased whole blood serotonin within the body. The condition is the most replicated biochemical abnormality associated with autism spectrum disorders (ASD). The etiology of this biomarker was poorly understood until now. A new French study published in […]

February 15, 2021

Another Suramin Study Shows Promise for Treating Core Symptoms of Autism

Research Involved an Intravenous Form of Suramin Called PAX-101 Exciting news surrounding a potential autism medication was delivered from New Jersey last week. PaxMedica, a biopharmaceutical company, announced impressive results from their phase 2 dose-ranging clinical trial investigating their product PAX-101 (IV suramin) as a potential therapeutic to alleviate core symptoms of autism spectrum disorder […]

February 15, 2021

Most Medical Doctors View the Lives of Individuals with Disabilities as Subpar

Lead Author of New Study Calls Findings, “Very Disturbing”  Approximately 12% of  Americans have at least one disability. Growing evidence shows that individuals living with disabilities experience healthcare disparities compared to the general population. A new study published in the journal Health Affairs was the first of its kind to examine doctors’ attitudes on treating […]

February 08, 2021

Psilocybin May Become a Future Autism Treatment

Psychedelics Show Promise for Treating Neuropsychiatric Disorders  Psilocybin is a hallucinogenic/psychedelic substance that works by activating serotonin receptors in the prefrontal cortex, the area of the brain that affects mood, cognition, and perception. Recently, psychedelics have shown acceptable safety and efficacy in treating various neuropsychiatric disorders. They have also demonstrated sustained prosocial behavior and helped […]

February 08, 2021

Newly Licensed Drivers with Autism Have Better Driving Records Than Neurotypical Peers

However, Additional Road Training May Benefit Drivers with ASD  A new study has found that young drivers with autism have lower rates of moving violations, license suspensions and crash rates compared to their neurotypical peers. This research was produced by a collaboration between the Center for Injury Research and Prevention (CIRP) and the Center for […]

February 02, 2021

Surprising New Findings Surrounding the Role of Astrocytes in the Brain and Gut

Advances in the Study of Astrocytes Show Promise in Controlling Brain Inflammation and Treating Epilepsy Astrocytes are the most common cells found within the central nervous system (CNS). Even though these cells are abundant, astrocytes have long been poorly understood. Now, two recent studies are shedding more light on the function of astrocytes. These new […]

Show Buttons
Hide Buttons